Loading...
A Phase 0 Trial of Riluzole in Patients with Resectable Stage III and IV Melanoma
PURPOSE: Ectopic expression of GRM1 in murine melanocytes results in transformation into a form of melanoma, and more than 60% of human melanoma samples tested ectopically express GRM1. Stimulation of this receptor in vitro results in up-regulation of activated extracellular signal–regulated kinase...
Na minha lista:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2009
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2812866/ https://ncbi.nlm.nih.gov/pubmed/19458050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-3303 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|